We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Annual Report of the Human Medicines Regulations 2012 Advisory Bodies - the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission.
MHRA annual report and accounts 2024 to 2025.
Information about how we handle potential corporate conflicts of interest (COI) between different parts of the Agency.
These reports outline the MHRA’s Corporate and Business Plans, detailing the agency's strategic direction over the next three years.
A programme to help decision making across the lifecycle of products, benefitting both regulatory and health technology assessment (HTA) evaluations.
Progress made in delivering the Patient Involvement Strategy, October 2021 - January 2025.
MHRA 2024-2027 Data Strategy sets out our five strategic themes for data and digital technology.
MHRA annual report and accounts 2023 to 2024.
Annual reports of the Advisory Board on the Registration of Homeopathic Products and the Herbal Medicines Advisory Committee.
MHRA annual report and accounts 2022 to 2023.
This People Strategy sets out the agency’s five core priorities over the next three years.
These equality objectives set out how the Medicines and Healthcare products Regulatory Agency (MHRA) will comply with the public sector equality duty.
Progress made in delivering the Patient Involvement Strategy, October 2021 - September 2022.
Putting patients first: a new era for our agency
Annual Report of the Human Medicines Regulations 2012 Advisory Bodies - the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission
MHRA annual report and accounts 2021 to 2022
This document contains the MHRA annual report and accounts 2020 to 2021.
Annual report from the MHRA on the regulation of medicines advertising to promote transparency.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).